Osteoprotegerin and Cardiovascular Events in High-Risk Populations: Meta-Analysis of 19 Prospective Studies Involving 27450 Participants
Tschiderer, L., Klingenschmid, G., Nagrani, R., Willeit, J., Laukkanen, J., Schett, G., Kiechl, S., & Willeit, P. (2018). Osteoprotegerin and Cardiovascular Events in High-Risk Populations: Meta-Analysis of 19 Prospective Studies Involving 27450 Participants. Journal of the American Heart Association, 7(16), Article e009012. https://doi.org/10.1161/JAHA.118.009012
Published inJournal of the American Heart Association
© 2018 The Authors
Background Osteoprotegerin is a cytokine involved in bone metabolism as well as vascular calcification and atherogenesis. Although circulating osteoprotegerin levels are robustly associated with incident cardiovascular disease (CVD) in the general population, its relevance as a biomarker among populations at high CVD risk is less clear. Methods and Results Three independent reviewers systematically searched PubMed, EMBASE, and Web of Science to identify prospective studies that had recruited participants on the basis of having conditions related to high CVD risk. A total of 19 studies were eligible for inclusion, reporting on 27 450 patients with diabetes mellitus (2 studies), kidney disease (7 studies), preexisting heart disease (5 studies), or recent acute coronary syndromes (5 studies) at baseline. Over a mean follow‐up of 4.2 years, 4066 CVD events were recorded. In a random‐effects meta‐analysis, the pooled risk ratio for CVD events comparing people in the top versus the bottom tertile of osteoprotegerin concentration was 1.30 (95% confidence interval, 1.12–1.50; P<0.001; I2=68.3%). There was evidence for presence of publication bias (P value from Egger's test=0.013). Correction for publication bias using the trim‐and‐fill method reduced the risk ratio to 1.21 (95% confidence interval, 1.03–1.42; P<0.001). The risk ratios did not vary significantly by population type, geographical region, statistical adjustment, sample or assay type, age, sex, or length of follow‐up. Conclusions In populations at high CVD risk, elevated circulating osteoprotegerin levels are associated with a higher risk for future CVD events. The magnitude of association appears weaker than in the general population. ...
PublisherAmerican Heart Association; Wiley
Publication in research information system
MetadataShow full item record
- Liikuntatieteiden tiedekunta 
Showing items with similar title or keywords.
Physical activity and risk of venous thromboembolism : systematic review and meta-analysis of prospective cohort studies Kunutsor, Setor K.; Mäkikallio, Timo H.; Seidu, Samuel; de Araújo, Claudio Gil Soares; Dey, Richard S.; Blom, Ashley W.; Laukkanen, Jari A. (Springer, 2020)The inverse association between physical activity and arterial thrombotic disease is well established. Evidence on the association between physical activity and venous thromboembolism (VTE) is divergent. We conducted a ...
Physical activity and risk of atrial fibrillation in the general population : meta-analysis of 23 cohort studies involving about 2 million participants Kunutsor, Setor K.; Seidu, Samuel; Mäkikallio, Timo H.; Dey, Richard S.; Laukkanen, Jari A. (Springer, 2021)Regular physical activity is well established to be associated with reduced risk of cardiovascular disease outcomes. Whether physical activity is associated with the future risk of atrial fibrillation (AF) remains a ...
Physical activity reduces the risk of pneumonia : systematic review and meta-analysis of 10 prospective studies involving 1,044,492 participants Kunutsor, Setor K.; Seidu, Samuel; Laukkanen, Jari A. (Springer Science and Business Media LLC, 2022)The beneficial effects of regular physical activity in promoting health and preventing chronic diseases are well documented. The relationship between regular physical activity and the risk of pneumonia is uncertain. We ...
Effect of Omega-3 Dosage on Cardiovascular Outcomes : An Updated Meta-Analysis and Meta-Regression of Interventional Trials Bernasconi, Aldo A.; Wiest, Michelle M.; Lavie, Carl J.; Milani, Richard V.; Laukkanen, Jari A. (Elsevier, 2021)Objectives:To quantify the effect of eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids oncardiovascular disease (CVD) prevention and the effect of dosage. Methods:This study is designed as a random effects meta-analysis ...
Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study Laukkanen, Tanjaniina; Kunutsor, Setor K.; Khan, Hassan; Willeit, Peter; Zaccardi, Francesco; Laukkanen, Jari (BioMed Central, 2018)Background: Previous evidence indicates that sauna bathing is related to a reduced risk of fatal cardiovascular disease (CVD) events in men. The aim of this study was to investigate the relationship between sauna habits ...